Tech Company Financing Transactions

Silvergate Pharmaceuticals Funding Round

On 6/30/2011, Silvergate Pharmaceuticals announced $3 million in financing from Frazier Healthcare Partners and private investors.

Transaction Overview

Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$3,015,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6251 Greenwood Plaza Blvd. 101
Greenwood Village, CO 80111
USA
Email Address
Overview
The company is developing technologies that reformulate adult pharmaceuticals for the pediatric market.
Profile
Silvergate Pharmaceuticals LinkedIn Company Profile
Social Media
Silvergate Pharmaceuticals Company Twitter Account
Company News
Silvergate Pharmaceuticals News
Facebook
Silvergate Pharmaceuticals on Facebook
YouTube
Silvergate Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Frank Segrave
  Frank Segrave LinkedIn Profile  Frank Segrave Twitter Account  Frank Segrave News  Frank Segrave on Facebook
Chief Financial Officer
Barry Barnard
  Barry Barnard LinkedIn Profile  Barry Barnard Twitter Account  Barry Barnard News  Barry Barnard on Facebook
VP - Bus. Development
Michael Beckloff
  Michael Beckloff LinkedIn Profile  Michael Beckloff Twitter Account  Michael Beckloff News  Michael Beckloff on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2011: ProMed venture capital transaction
Next: 6/30/2011: ScholarPRO venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary